The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
({4-[2-Acetylamino-2-(1-biphenyl-4-ylmethyl-2-oxo-azepan-3-ylcarbamoyl)-ethyl]-phenyl}-difluoro-methyl)-phosphonic acid ID: ALA1160756
PubChem CID: 447523
Max Phase: Preclinical
Molecular Formula: C31H34F2N3O6P
Molecular Weight: 613.60
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: CC(=O)N[C@@H](Cc1ccc(C(F)(F)P(=O)(O)O)cc1)C(=O)N[C@H]1CCCCN(Cc2ccc(-c3ccccc3)cc2)C1=O
Standard InChI: InChI=1S/C31H34F2N3O6P/c1-21(37)34-28(19-22-12-16-26(17-13-22)31(32,33)43(40,41)42)29(38)35-27-9-5-6-18-36(30(27)39)20-23-10-14-25(15-11-23)24-7-3-2-4-8-24/h2-4,7-8,10-17,27-28H,5-6,9,18-20H2,1H3,(H,34,37)(H,35,38)(H2,40,41,42)/t27-,28-/m0/s1
Standard InChI Key: LVZDQVATAQEMCX-NSOVKSMOSA-N
Molfile:
RDKit 2D
43 46 0 0 0 0 0 0 0 0999 V2000
2.6448 1.6713 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8198 1.6713 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4073 2.3857 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8198 3.1002 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6448 3.1002 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0573 2.3857 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4073 3.8147 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.6929 3.4022 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
2.1218 4.2272 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
0.9948 4.5291 0.0000 P 0 0 0 0 0 0 0 0 0 0 0 0
0.5823 5.2436 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.2804 4.1166 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.7093 4.9416 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.0573 0.9568 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6448 0.2423 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8198 0.2423 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4073 -0.4721 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.4073 0.9568 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.0573 -0.4721 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.8823 -0.4721 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2948 0.2423 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.2948 -1.1866 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.5823 -0.4721 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2244 -1.2154 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.5799 -1.3990 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.7388 -1.8605 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.2249 -0.8846 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2249 -0.0596 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.7635 -2.2033 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.5519 -2.4465 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.5799 0.4547 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2244 0.2712 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7354 -3.2508 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5238 -3.4940 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.1286 -2.9329 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.9450 -2.1285 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.1566 -1.8854 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.9169 -3.1760 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.1005 -3.9803 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.8888 -4.2235 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.4936 -3.6624 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.3100 -2.8581 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.5217 -2.6149 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
1 6 2 0
1 14 1 0
2 3 2 0
3 4 1 0
4 5 2 0
7 4 1 0
5 6 1 0
7 8 1 0
7 9 1 0
7 10 1 0
11 10 2 0
12 10 1 0
13 10 1 0
14 15 1 0
15 16 1 0
15 19 1 6
16 17 1 0
16 18 2 0
23 17 1 6
20 19 1 0
20 21 2 0
20 22 1 0
23 24 1 0
23 32 1 0
24 25 1 0
24 26 2 0
27 25 1 0
29 25 1 0
27 28 1 0
28 31 1 0
29 30 1 0
30 33 1 0
30 37 2 0
31 32 1 0
33 34 2 0
34 35 1 0
35 36 2 0
35 38 1 0
36 37 1 0
38 39 1 0
38 43 2 0
39 40 2 0
40 41 1 0
41 42 2 0
42 43 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 613.60Molecular Weight (Monoisotopic): 613.2153AlogP: 4.33#Rotatable Bonds: 10Polar Surface Area: 136.04Molecular Species: ACIDHBA: 4HBD: 4#RO5 Violations: 1HBA (Lipinski): 9HBD (Lipinski): 4#RO5 Violations (Lipinski): 1CX Acidic pKa: 0.49CX Basic pKa: ┄CX LogP: 3.28CX LogD: 0.53Aromatic Rings: 3Heavy Atoms: 43QED Weighted: 0.25Np Likeness Score: -0.49
References 1. Lange G, Lesuisse D, Deprez P, Schoot B, Loenze P, Bénard D, Marquette JP, Broto P, Sarubbi E, Mandine E.. (2002) Principles governing the binding of a class of non-peptidic inhibitors to the SH2 domain of src studied by X-ray analysis., 45 (14): [PMID:12086479 ] [10.1021/jm0110800 ] 2. Lange G, Lesuisse D, Deprez P, Schoot B, Loenze P, Bénard D, Marquette JP, Broto P, Sarubbi E, Mandine E.. (2003) Requirements for specific binding of low affinity inhibitor fragments to the SH2 domain of (pp60)Src are identical to those for high affinity binding of full length inhibitors., 46 (24): [PMID:14613321 ] [10.1021/jm020970s ]